These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1071407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG, Parker FB, Poirier RA, Anderson G, Streeten DH, Blackman M.
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R.
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM, Case DB, Laragh JH, Sealey JE, Keim HJ, Drayer JI.
    Trans Assoc Am Physicians; 1977 Mar; 90():300-12. PubMed ID: 205983
    [Abstract] [Full Text] [Related]

  • 14. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ, Baer L, Radichevich I.
    Cardiovasc Clin; 1978 Mar; 9(1):183-95. PubMed ID: 667880
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin II blockade in hypertensive dialysis patients.
    MacGregor GA, Dawes PM.
    Prog Biochem Pharmacol; 1976 Mar; 12():190-9. PubMed ID: 1019164
    [Abstract] [Full Text] [Related]

  • 16. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M, Passalacqua W, Plaza de los Reyes X, Pla C, Campino C.
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract] [Full Text] [Related]

  • 17. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 18. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R, Lijnen P, Amery A, Reybrouck T.
    Contrib Nephrol; 1978 Aug; 11():175-8. PubMed ID: 699588
    [Abstract] [Full Text] [Related]

  • 19. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G.
    Boll Soc Ital Biol Sper; 1980 Jul 15; 56(13):1367-73. PubMed ID: 7004464
    [Abstract] [Full Text] [Related]

  • 20. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP, Ledingham JG.
    Clin Sci Mol Med; 1978 Mar 15; 54(3):305-12. PubMed ID: 630806
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.